ForeverGreen reports decrease in revenue for second quarter 2010

NewsGuard 100/100 Score

ForeverGreen Worldwide Corp. (OTCBB: FVRG), www.forevergreen.com, manufacturer and distributor of all natural whole foods, today announced that it has filed 2010 Q2 financial reports.

The company reported revenues of $2,423,082 during Q2 2010, ending 6/30/10 versus $3,330,979 during the comparable period in 2009.

The company reported a net loss of $95,427 or .01 EPS compared to a loss of $142,480 or .01 during the same period last year.

Additionally, Q2 2010 second quarter accomplishments include:

  • Introduction of a new compensation plan, supplemented on 7/27/10, called "The People's Plan"
  • Company took steps for necessary cost reductions for future profitability
  • Cost of sales was reduced to 67.0% compared to 70.8% during the same timeframe last year
  • Introduced a new product, "Pure," a unique concentrate of unique marine phytoplankton product
  • Concentrating on building high growth in international markets - seeing Spanish speaking countries and Asia growth of over 10% per month

"ForeverGreen's international markets, especially Latin America, will help accelerate our growth and momentum as we move further into 2010. We believe that the opening of new markets as well as the introduction of new products and a new compensation plan bode well for our future. When coupled with the lowering overhead costs we look forward to a better financial situation as we head into the latter part of the year," said Ron Williams, ForeverGreen CEO.

Source: ForeverGreen

Posted in:

Tags:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.